On the recordJune 7, 2017
Is it appropriate to give pharmaceutical companies a $25-billion tax cut in the health-care reform bill when there is nothing to bring down the cost of prescription drugs in that bill?
Source
congress.govIs it appropriate to give pharmaceutical companies a $25-billion tax cut in the health-care reform bill when there is nothing to bring down the cost of prescription drugs in that bill?
Stabenow questions the appropriateness of tax cuts for pharma without lowering drug costs.
Share
More from Debbie Stabenow
I predict a very good Democratic year in 2026 regardless of what happens in a Democratic primary.
Well, first of all, let me say the basic program is called SNAP, the Supplemental Nutrition Assistance Program, is about $6 a day for an individual. So a mom gets $6; her child gets $6.
Well, if we do nothing, then a number of programs revert to what is called a Depression-era policy, and there is something called the dairy cliff that everybody is always worried about because it goes back to a pricing structure that would…